Results 21 to 30 of about 48,070 (253)
The effect of digoxin on renal function in patients with heart failure
Introduction Digoxin is used in patients with chronic heart failure (CHF) who remain symptomatic despite optimal medical treatment. Impaired renal function is commonly associated with CHF.
Parin Shah +5 more
doaj +1 more source
A 5 years assessment of patients with acute digoxin poisoning: A toxicoepidemiology study in Iran
Background: Digoxin poisoning leads to the development of cardiac and noncardiac complications. Digoxin immune fab is a safe and effective antidote, but clinical trials have not been performed in this regard, and most of the evidence is based on ...
Mitra Rahimi +3 more
doaj +1 more source
Bioavailability of Digoxin and Beta-Methyl-Digoxin
In a randomized crossover study the bioavailability of a single dose of digoxin and of beta-methyl-digoxin tablets was tested in four normal volunteers. No difference was found between the two products in the rate and extent of drug absorption using 6 day cumulative urinary excretion and serial serum concentration measurements.
L, Padeletti +3 more
openaire +2 more sources
Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6)
For acute digoxin poisoning, it has been recommended to give bolus doses of 10–20 vials or potentially larger than needed doses calculated from dose ingested or the measured concentration. However, a recent revision of internal Poisons Information Centre
Geoffrey K. Isbister (8281572) +4 more
core +1 more source
Ten years of experience in treating patients with digoxin toxicity without the use of Digoxin Fab antibodies [PDF]
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are recommended to be used in patients with cardiac symptoms of digoxin toxicity,
Meamar, Rokhsareh +7 more
core +1 more source
Tissue digoxin concentrations and digoxin effect during the quinidine-digoxin interaction
Quinidine elevates serum digoxin concentration in part by reducing the volume of distribution of digoxin, which implies that quinidine displaces digoxin from tissues. The purposes of this study were to: 1) measure the effect of quinidine on tissue digoxin concentrations, and 2) determine if quinidine alters the relation between myocardial digoxin ...
Warner, Natalie J. +2 more
openaire +2 more sources
Digoxin and Heart Failure: Are We Clear Yet?
The Digoxin Investigation Group trial has multiple flaws in the trial design for the findings to be universally applicable. Digoxin in low serum concentrations (0.5–0.9 ng/mL) has been shown to decrease mortality in heart failure patients.
Amit Gupta, Melissa Dakkak, Alan Miller
doaj +1 more source
Background. Monitoring of serum digoxin concentration (SDC) is one of the approaches for controlling the safety of the long-term digoxin treatment, however, the benefits from SDC monitoring in paroxysmal arrhythmias have not been studied.Aim. To evaluate
S. F. Zadvorev +5 more
doaj +1 more source
Background Digoxin acutely increases cardiac output in patients with pulmonary arterial hypertension (PAH) and right ventricular failure; however, the effects of chronic digoxin use in PAH are unclear.
Kevin Y. Chang +8 more
doaj +1 more source
BACKGROUND: Thalassaemia is a hereditary disorder and has an economic burden on patients and the government. The most prevalent complication in these patients is iron overload which is followed by cardiomyopathy.
Beydolah Shahouzehi +2 more
doaj +1 more source

